Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Thomas Tipih
Pathogenesis of bovine H5N1 clade 2.3.4.4b infection in Macaques - Nature
Abstract Since early 2022 highly pathogenic avian influenza (HPAI) H5N1 virus infections have been reported in wild aquatic birds and poultry throughout the United States (US) with spillover into several mammalian species1-6. In March 2024, HPAIV H5N1 clade 2.3.4.4b was first detected in dairy cows in Texas, US and continues to circulate on dairy farms in multiple states7,8.
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice - Nature Communications
Abstract The ongoing circulation of influenza A H5N1 in the United States has raised concerns of a pandemic caused by highly pathogenic avian influenza. Although the United States has stockpiled and is prepared to produce millions of vaccine doses to address an H5N1 pandemic, currently circulating H5N1 viruses contain multiple mutations within the immunodominant head domain of hemagglutinin (HA) compared to the antigens used in stockpiled vaccines.
Recent Bovine HPAI H5N1 Isolate is Highly Virulent for Mice, Rapidly Causing Acute Pulmonary and Neurologic Disease
Abstract The highly pathogenic avian influenza (HPAI) A(H5N1) clade 2.3.4.4b viruses, responsible for the current outbreak in dairy cows in the United States, pose a significant animal and public health threat. In this study, we compared disease progression and pathology of three recent clade 2.3.4.4b isolates derived from a cow, mountain lion, and mink to a human HPAI A(H5N1) isolate from Vietnam in mice.
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
Research Article | Clinical Science and Epidemiology Wern Hann Ng, Thomas Tipih, Nigel A. Makoah, Jan-G Vermeulen, Dominique Goedhals, Joseph B. Sempa, Felicity J. Burt, Adam Taylor, Suresh Mahalingam Diane E. Griffin, Editor DOI: 10.1128/mBio.03647-20 ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe at unprecedented speed and is showing no signs of slowing down.
Crimean-Congo Hemorrhagic Fever Virus: Advances in Vaccine Development
Introduction Background Crimean–Congo hemorrhagic fever virus (CCHFV) is exclusively associated with a virulent disease in humans. In the absence of approved therapeutics or vaccines against the virus, treatment is predominantly supportive. CCHFV possesses a trisegmented negative-sense RNA genome and is classified within the Orthonairovirus genus of the Nairoviridae family.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Thomas
Contact Thomas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack